CONGENITAL HYPERINSULINISM
Clinical trials for CONGENITAL HYPERINSULINISM explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL HYPERINSULINISM trials appear
Sign up with your email to follow new studies for CONGENITAL HYPERINSULINISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended trial tests drug to control rare childhood blood sugar disorder
Disease control OngoingThis study is following children with congenital hyperinsulinism (CHI) to see how safe and effective the drug dasiglucagon is over a long period. CHI causes dangerously low blood sugar. The drug is given as a continuous infusion under the skin. The main goal is to monitor side ef…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug trial aims to tame rare, dangerous low blood sugar disorder
Disease control OngoingThis study is testing if an investigational drug called RZ358 can help people with congenital hyperinsulinism, a rare genetic disorder that causes dangerously low blood sugar. About 56 participants, from infants to adults, will receive RZ358 or a placebo along with their standard…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE3 • Sponsor: Rezolute • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC